Childhood Nephrotic Syndrome Management and Outcome: A Single Center Retrospective Analysis
Table 1
Characteristics of patients with childhood nephrotic syndrome diagnosed between 2006 and 2012 in the Atlanta MSA.
Characteristic
SSNS
FRNS/SDNS
SRNS
Total
Sex
Male
17 (74)
32 (67)
9 (56)
58 (67)
Female
6 (26)
16 (33)
7 (44)
29 (33)
Age at diagnosis
1–5 years
17 (74)
27 (56)
3 (19)
47 (54)
6–12 years
6 (26)
15 (31)
5 (31)
26 (30)
13–18 years
0 (0)
6 (13)
8 (50)
14 (16)
Race and ethnicity
White, non-Hispanic
6 (26)
15 (31)
2 (13)
23 (26)
Black
7 (30)
19 (40)
13 (81)
39 (45)
White, Hispanic
4 (17)
9 (19)
1 (6)
14 (16)
Other
6 (26)
5 (10)
0 (0)
11 (13)
Insurance
Private
11 (48)
22 (46)
6 (38)
39 (45)
Medicaid
11 (48)
23 (48)
8 (50)
42 (48)
None
1 (4)
3 (6)
2 (13)
6 (7)
Histopathology
No biopsy
22 (96)
27 (56)
2 (13)
51 (59)
MCD
0 (0)
17 (35)
5 (31)
22 (25)
FSGS
1 (4)
1 (2)
6 (38)
8 (9)
Other
0 (0)
3 (6)
3 (19)
6 (8)
Comorbidity
None
19 (83)
40 (83)
11 (69)
70 (80)
Asthma
3 (13)
7 (15)
1 (6)
11 (13)
Epilepsy
1 (4)
0 (0)
2 (13)
3 (3)
Inflammatory bowel disease
0 (0)
1 (2)
1 (6)
2 (2)
Prematurity
0 (0)
2 (4)
0 (0)
2 (2)
Other
1 (4)
1 (2)
1 (6)
3 (3)
Data are presented as the number of patients with the percentage in parenthesis. FRNS, frequently relapsing nephrotic syndrome; MCD, minimal change disease; FSGS, focal segmental glomerulosclerosis; SDNS, steroid-dependent nephrotic syndrome; SRNS, steroid-resistant nephrotic syndrome; SSNS, steroid-sensitive and infrequently relapsing nephrotic syndrome.
